© Oxford University Press 2005; all rights reserved
Case Reports |
Successful Unrelated Cord Blood Transplantation in a Child with ß-Thalassemia Major
1 Divisions of Hematology and Oncology, Department of Pediatrics, Chang Gung Children's Hospital, Taiwan, 2 Division of Infectious Disease, Department of Pediatrics, Chang Gung Children's Hospital, Taiwan, 3 StemCyte Taiwan National Cord Blood Center, Linko, Taiwan, 4 Graduate Institute of Nursing Science, Chang Gung University, Taoyuan, Taiwan
Tang-Her Jaing, MD, Division of Hematology and Oncology, Department of Pediatrics, Chang Gung Children's Hospital, 5 Fu-Shin Street, Kwei-Shan, 333 Taoyuan, Taiwan. E-mail <jaing001{at}cgmh.org.tw>.
We report here the first successful transplant of unrelated umbilical cord blood (UCB) for a child with ß-thalassemia major in Taiwan. A total of 2.48 x 105/kg CD34 cells were infused into a 3
-year-old girl following conditioning with a pre-transplant cytoreductive/immunosuppressive regimen of busulfan and cyclophosphamide. The absolute neutrophil count first exceeded 0.5 x 109/l on day 17, and the patient became red cell- and platelet-independent on days 34 and 49, respectively. Engraftment of donor hematopoietic populations was documented by cytogenetic analysis, hemoglobin electrophoresis, Southern blot analysis for thalassemia markers, and molecular analysis of short tandem repeats sequences. The patient was ex-thalassemic for more than 15 months post transplant. From this experience, it is postulated that UCB will indeed allow us to expand the available donor pool for recipients with an HLA DRB1 mismatched at one locus and reduce the risk of graft-versus-host disease.